6Weber B. Recent development in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.Expert Rev Mol Diagn, 2005,5 ( 1 ) : 75 -91.
7KIM H J, FAY M P, FEUER E J, et al. Permutation tests for jionpoint regression with applications to cancer rates[J]. StatMed, 2000, 19(3):335-351.
8MOLLER B, FEKJAER H, HAKULINEN T, et al. Prediction of cancer incidence in the Nordic countries up to the year 2020[J]. EurJ Cancer Prev, 2002, 11 (Suppll):S1-96.
9NOWATZKI J, MOLLER B, future cancer incidence Manitoba, 2006-2025[.I] 31 (2):71-78. DEMERS A. Projection of and new cancer cases in Chronic Dis Can, 2011,.
10OLSEN A H, PARKIN D M, SASIENI P. Cancer mortality in the United Kingdom: projections to the year 2025[J]. BrJ Cancer, 2008, 99(9): 1549-1554.
